Data as of May 23
| +0.47 / +4.62%|
The 7 analysts offering 12-month price forecasts for OncoGenex Pharmaceuticals Inc have a median target of 30.00, with a high estimate of 38.00 and a low estimate of 19.00. The median estimate represents a +181.95% increase from the last price of 10.64.
The current consensus among 8 polled investment analysts is to Buy stock in OncoGenex Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.